EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|3|1|37-52

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.3, Iss.1, 2010-01, pp. : 37-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma

By Cassell Andre   Grandis Jennifer R  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 709-722

Informa Healthcare

Access to resources Recommend Favorite

Structural Basis for Drug Resistance Mechanisms Against EGFR

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2509-2521

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging targeted treatments for malignant glioma

By Mulholland Paul J   Thirlwell Christina   Brock Cathryn S   Newlands Edward S  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 845-854

Informa Healthcare

Access to resources Recommend Favorite

Novel Agents in Anticancer Drug Therapy I (Antiangiogenic Agents, Egfr Inhibitors)

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 6, 2005-12 ,pp. : 489-494

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells

By Mamot Christoph   Ritschard Reto   Küng Willy   Park John W.   Herrmann Richard   Rochlitz Christoph F.  

Journal of Drug Targeting, Vol. 14, Iss. 4, 2006-05 ,pp. : 215-223

Informa Healthcare

Access to resources Recommend Favorite